Agile Therapeutics Inc. (AGRX)
NASDAQ: AGRX
· Real-Time Price · USD
1.51
0.05 (3.42%)
At close: Aug 22, 2024, 7:58 PM
3.42% (1D)
| Bid | n/a |
| Market Cap | 10.43M |
| Revenue (ttm) | 21.57M |
| Net Income (ttm) | -15.86M |
| EPS (ttm) | -1.7 |
| PE Ratio (ttm) | -0.888235294117647 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 119,291 |
| Avg. Volume (20D) | 143,293 |
| Open | 1.48 |
| Previous Close | 1.46 |
| Day's Range | 1.44 - 1.51 |
| 52-Week Range | 0.20 - 2.63 |
| Beta | 1.58 |
About AGRX
Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to h...
Full Company Profile